Literature DB >> 33759138

LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination.

Huajie Cai1, Yihu Zheng1, Zhengde Wen1, Yingnan Yang1, Shouzhang Yang1, Qiyu Zhang2.   

Abstract

Long non-coding RNAs (LncRNAs) have been implicated in the pathogenesis of various human diseases. In this study, we probed into the role and potential mechanisms of the antisense of IGF2R non-protein coding RNA (LncRNA AIRN) in the progression of hepatocellular carcinoma (HCC). Using a quantitative real-time polymerase chain reaction, we corroborated that LncRNA AIRN expression was raised in the HCC tissues and cells. The bioinformatic analysis revealed that a potential interaction between LncRNA AIRN and STAT1, which was verified by the RNA pull-down and RNA immunoprecipitation. In the cycloheximide-chase assay, the knockdown of LncRNA AIRN enhanced the stability of STAT1 protein. In the immunoprecipitation assay, the knockdown of LncRNA AIRN restrained the cullin 4A (CUL4A)-mediated ubiquitination of STAT1 protein. The cell transfection, MTT and flow cytometry assays expounded that the LncRNA AIRN/STAT1 axis was bound up with the regulation of the proliferation and apoptosis of HCC cells. The in vivo experiments corroborated that the knockdown of LncRNA AIRN restrained the tumor growth of HCC. Our data expounded that the knockdown of LncRNA AIRN restrained HCC cell proliferation and boosted cell apoptosis by restraining the CUL4A-mediated ubiquitination of STAT1 protein.

Entities:  

Keywords:  CUL4A; HCC; LncRNA AIRN; STAT1; Ubiquitination

Year:  2021        PMID: 33759138     DOI: 10.1007/s12272-021-01317-7

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  27 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

Review 2.  Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

Authors:  Yong He; Xiao-Ming Meng; Cheng Huang; Bao-Ming Wu; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Cancer Lett       Date:  2013-10-30       Impact factor: 8.679

Review 3.  Targeting long non-coding RNAs in cancers: progress and prospects.

Authors:  Chi Han Li; Yangchao Chen
Journal:  Int J Biochem Cell Biol       Date:  2013-06-04       Impact factor: 5.085

4.  Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.

Authors:  Anja Lautem; Frank Simon; Maria Hoppe-Lotichius; Jens Mittler; Johanna Vollmar; Arno Schad; Christoph Düber; Peter Robert Galle; Gerd Otto; Tim Zimmermann; Hauke Lang
Journal:  Oncol Rep       Date:  2019-02-01       Impact factor: 3.906

5.  STAT1 negatively regulates hepatocellular carcinoma cell proliferation.

Authors:  Guofu Chen; Haihe Wang; Shuli Xie; Jian Ma; Guangyi Wang
Journal:  Oncol Rep       Date:  2013-04-09       Impact factor: 3.906

6.  Linker Histone H1.2 cooperates with Cul4A and PAF1 to drive H4K31 ubiquitylation-mediated transactivation.

Authors:  Kyunghwan Kim; Bomi Lee; Jaehoon Kim; Jongkyu Choi; Jin-Man Kim; Yue Xiong; Robert G Roeder; Woojin An
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

7.  Long noncoding RNA LNC473 inhibits the ubiquitination of survivin via association with USP9X and enhances cell proliferation and invasion in hepatocellular carcinoma cells.

Authors:  Hui Chen; Fan Yang; Xun Li; Zuo-Jiong Gong; Lu-Wen Wang
Journal:  Biochem Biophys Res Commun       Date:  2018-04-01       Impact factor: 3.575

Review 8.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.

Authors:  Véronique Baud; Michael Karin
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

9.  LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis.

Authors:  Jinglan Jin; Hongqin Xu; Wanyu Li; Xiaotong Xu; Huan Liu; Feng Wei
Journal:  Front Bioeng Biotechnol       Date:  2020-02-18

10.  STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7.

Authors:  Jiayu Chen; Haihe Wang; Jing Wang; Shishun Huang; Wei Zhang
Journal:  Cancer Cell Int       Date:  2015-11-26       Impact factor: 5.722

View more
  3 in total

1.  Isoorientin suppresses sepsis-induced acute lung injury in mice by activating an EPCR-dependent JAK2/STAT3 pathway.

Authors:  Mu Hu; Jielai Yang; Yang Xu
Journal:  J Mol Histol       Date:  2021-11-17       Impact factor: 2.611

2.  Inhibitory effects of 6'-sialyllactose on angiotensin II-induced proliferation, migration, and osteogenic switching in vascular smooth muscle cells.

Authors:  Thuy Le Lam Nguyen; Yujin Jin; Lila Kim; Kyung-Sun Heo
Journal:  Arch Pharm Res       Date:  2022-09-07       Impact factor: 6.010

3.  CDKN2B antisense RNA 1 expression alleviates idiopathic pulmonary fibrosis by functioning as a competing endogenouse RNA through the miR-199a-5p/Sestrin-2 axis.

Authors:  Mei Yang; Egao Yin; Yiheng Xu; Yongjun Liu; Ting Li; Zhaoxing Dong; Wenlin Tai
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.